TCI Wealth Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

TCI Wealth Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$2K	–	2549
2021 Q1	$2K	Buy	+50	New	+$1.25K	﹤0.01%	2008
2015 Q3	–	Sell	-500	Closed	-$12K	–	1034
2015 Q2	$12K	Buy	+500	New	+$11.1K	0.01%	494

TCI Wealth Advisors's FPRX Position: Q2 2021 in Review

TCI Wealth Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 50 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in FPRX in Q2 2015 and held it in 2 quarters. The position peaked at $12K in Q2 2015. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

TCI Wealth Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
TCI Wealth Advisors sold 50 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2K.
TCI Wealth Advisors first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 2 quarters.
TCI Wealth Advisors's Five Prime Therapeutics, Inc. position peaked at $12K in Q2 2015.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on TCI Wealth Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.